Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 02, 2026
Hyperscale Data (GPUS) Stock Declines -15% Over 30 Days Amid AI Data Center Shift

Hyperscale Data (GPUS) Stock Declines -15% Over 30 Days Amid AI Data Center Shift

Key Takeaways

  • Hyperscale Data shares declined roughly 15% over the last 30 days, slipping from a closing price of about $0.1984 in early September to about $0.17 in early October.
  • The move extends a longer downtrend: on a split-adjusted basis, the stock has fallen approximately 76% over the trailing three months.
  • The decline follows a 1-for-5 reverse stock split effective August 24, 2026, after which selling pressure persisted.
  • Hyperscale Data is pivoting from Bitcoin mining to AI data center operations at its Michigan facility under a master services agreement.
  • The company held about $56 million in Bitcoin, cash, and restricted cash as of September 27, 2026 — roughly 153% of its common-stock market capitalization.
  • Persistent operating losses, negative cash flow, and financing concerns remain key overhangs on the stock.

Company Overview for Hyperscale Data (GPUS)

Hyperscale Data, Inc. (GPUS) is an artificial-intelligence data center company anchored by Bitcoin. Formerly known as Ault Alliance, the company rebranded in September 2024 to reflect a strategic shift toward data center operations. Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center that offers colocation and hosting services for AI ecosystems and other industries. Its other subsidiary, Ault Capital Group, Inc. (ACG), operates as a hybrid private equity and operating company spanning financial services, digital assets, industrial services, hospitality, and defense technologies.

Investors follow GPUS primarily for its transition from Bitcoin mining to high-performance computing and AI data center services, centered on a Michigan campus with roughly 340 megawatts of potential power capacity. As a micro-cap company that has reported persistent losses, the stock carries elevated volatility and is closely tied to Bitcoin prices, AI infrastructure demand, and the company's financing execution. I also checked comparable names in the sector using Tickeron’s AI Screener to put the transition in context.

Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, GPUS has moved lower. The stock closed near $0.1984 in early September and traded around $0.17 in early October, a decline of roughly 15%. The move was uneven: the shares slipped below $0.16 at one point in late September before recovering slightly.

The pullback is part of a broader slide. On a split-adjusted basis reflecting the company's August 2026 reverse split, the stock has fallen approximately 76% over the trailing three months, from roughly $0.70 in early July to about $0.17 in early October. The persistent downtrend reflects the combination of the reverse split, ongoing dilution, and the market's reassessment of the company's AI data center transition.

Key Developments Shaping GPUS Over the Last 30 Days

Several company-specific developments shaped GPUS over the last 30 days. On September 2, Hyperscale Data announced it had ceased all Bitcoin mining at its Michigan facility, effective September 1, as part of preparing the site for AI data center deployment under its master services agreement (MSA). The company separately disclosed it had sold about 65 Bitcoin for roughly $5.1 million during the week ended August 30 to help fund the data center buildout.

The company also provided progress updates on the Michigan facility. On September 17, Hyperscale Data said it had invested more than $70 million in Alliance Cloud Services and the Michigan campus and was targeting the start of operations under the MSA in November 2026. The MSA covers an initial 20 megawatts of critical AI compute capacity with a 10-year term, and it carries expansion options that could lift contracted value beyond $3 billion over a 20-year horizon.

Despite these operational milestones, the stock remained under pressure. The 1-for-5 reverse split that took effect on August 24, 2026 — aimed at raising the share price and supporting exchange-listing compliance — was followed by continued selling. Persistent operating losses, negative cash flow, a heavy debt load, and concerns about future equity financing and dilution have all weighed on investor sentiment, offsetting the positive tone of the company's data center announcements.

Drivers Behind the Quarter's Performance

Over the trailing quarter, GPUS declined sharply, reflecting a fundamental repositioning of the business rather than a single event. The company has been shifting away from Bitcoin mining toward AI and high-performance computing data center services, a transition that involves substantial capital expenditures, equipment procurement, and execution risk.

The quarter also included the completion of the reverse stock split and a series of Bitcoin sales to fund development, which highlighted the company's reliance on asset sales and equity financing to support growth. Weak operating metrics — including negative operating margins and negative free cash flow — combined with a micro-cap share structure and dilution concerns to drive the stock lower over the period. The broader market's focus on AI infrastructure spending provided a supportive backdrop, but it was not enough to offset company-specific financial pressures.

What to Watch Next for GPUS

Looking ahead, the key catalyst for GPUS is execution of the Michigan AI data center. The company expects operations under its master services agreement to begin in November 2026, which would mark the transition to recurring revenue and cash flow generation. Investors will monitor whether the initial 20 megawatts come online on schedule and whether the customer exercises its expansion options.

Other factors to watch include the company's Bitcoin and cash position, which stood at about $56 million as of late September; the value of that treasury will fluctuate with Bitcoin prices. Financing and dilution remain important risks, as the company has historically relied on equity programs and asset sales to fund development. The planned 2027 divestiture of Ault Capital Group, continued compliance with exchange listing requirements, and the company's path toward positive cash flow will also shape the outlook. Macro conditions, including AI infrastructure spending and digital-asset prices, are additional variables for investors to follow. From what I see, tracking these milestones closely will be essential.

AI Tools in My Research Workflow

In my analysis of names like GPUS, I frequently use Tickeron’s AI Trading Bots to test systematic approaches to volatile micro-caps and transitions like this one. The platform’s curated selection of bots covers various strategies and timeframes, helping me review data-driven signals alongside fundamental developments without replacing my own judgment. This approach keeps my process efficient while highlighting potential patterns in real time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GPUS

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


GPUS's RSI Indicator entering oversold zone

The RSI Indicator for GPUS moved into overbought territory on October 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for GPUS just turned positive on September 15, 2026. Looking at past instances where GPUS's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

Following a +4.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where GPUS advanced for three days, in 121 of 154 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GPUS as a result. In 78 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GPUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for GPUS entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.210) is normal, around the industry mean (5.977). P/E Ratio (0.012) is within average values for comparable stocks, (53.565). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.772). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.082) is also within normal values, averaging (2.059).

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. GPUS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GPUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are 3M Company (NYSE:MMM), Honeywell International (NASDAQ:HON).

Industry description

Industrial Conglomerates specialize in numerous types of products, most of which comprise industrial goods, while some also go towards meeting household needs. Honeywell (makes engineering services and aerospace systems), United Technologies Corporation(manufactures aircraft engines, aerospace systems, HVAC, elevators and escalators, fire and security, building systems, and industrial products, among others), 3M (over 60,000 products under several world-renowned brands, including adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical & electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films).

Market Cap

The average market capitalization across the Industrial Conglomerates Industry is 6.62B. The market cap for tickers in the group ranges from 62.16K to 156.47B. HTHIF holds the highest valuation in this group at 156.47B. The lowest valued company is FSTF at 62.16K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Conglomerates Industry was -1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -1%. NNBR experienced the highest price growth at 14%, while NXAT experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Industrial Conglomerates Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was -75% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 59
Price Growth Rating: 58
SMR Rating: 73
Profit Risk Rating: 82
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
GPUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry IndustrialConglomerates

Industry
N/A
Address
11411 Southern Highlands Parkway
Phone
+1 949 444-5464
Employees
612
Web
https://www.hyperscaledata.com
Interact to see
Advertisement
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
RH shares are down approximately 17% in premarket trading on April 1, 2026, after closing the previous session at $139.82, with the stock indicated near $115.76 — a decline of roughly $24 per share. The primary catalyst is a significant Q4 fiscal year 2025 earnings miss, with adjusted EPS of $1.53 coming in well below the Wall Street consensus of $2.22 — a 31% negative surprise.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
WDC shares surged approximately +10% in Wednesday's session, advancing to approximately $296–$297 from a prior close near $269.82 on March 31, 2026. The primary catalyst is a major analyst upgrade: Bernstein raised its rating on Western Digital from Market Perform to Outperform and dramatically doubled its price target to $340 from $170.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.